July 20, 2025
-
MDL Status Conference Details: A nearly two-hour Zoom status conference reviewed the progress of the Suboxone MDL. Discussions included handling missing claim documents, redacting old deposition transcripts, finalizing authorization forms, tracking new claims, and managing future document production from key individuals. The judge resolved two disputes regarding Rule 30(b)(6) deposition notices and set deadlines for proposing a plan for non-custodial document collection by August 15, 2025, and submitting fact sheets by September 29, 2025. The next in-person hearing is set for September 9, 2025.
July 17, 2025
-
Indivior's Settlement Strategy Questioned: Indivior's approach to settlement, which may rely on how jurors perceive individuals in recovery from addiction, is being questioned by plaintiffs' lawyers. They suggest this strategy is flawed and could lead to substantial financial losses for the company if cases proceed to trial, emphasizing the plaintiffs' experiences and the extent of their dental injuries.
July 11, 2025
-
Suboxone Lawsuit Profile Changing: The Suboxone litigation is drawing increased attention. Plaintiffs, often individuals in recovery facing significant dental reconstruction costs due to the drug, could influence public perception and potentially alter Indivior's risk assessment if their stories become widely known or are presented at trial.
July 8, 2025
-
New Deposition Protocols Issued: The MDL judge has issued a new order outlining procedures for conducting depositions for both general witnesses and those involved in bellwether cases. The order specifies rules for in-person and remote depositions, exhibit handling, scheduling, and lawyer participation, aiming to maintain efficiency during the discovery phase.
July 3, 2025
-
Indivior's Defense Strategy Under Scrutiny: Indivior's defense strategy, which might assume juries will be less sympathetic to plaintiffs due to their history of opioid addiction, is being critically examined. Plaintiffs' lawyers argue this is a miscalculation, highlighting the trust plaintiffs placed in Suboxone and the resulting dental damage. They suggest that juries will react negatively to a company that allegedly failed to warn about product risks.
June 10, 2025
- Challenges in Obtaining Pharmacy Records: A key challenge in the Suboxone litigation involves obtaining pharmacy records. A show-cause order against Walgreens Pharmacy remains in place due to alleged non-compliance with Case Management Order No. 13, which mandates record production within 30 days of receiving valid medical authorizations.
June 5, 2025
- Bellwether Plaintiff Replacements: Following the issuance of Amended Case Management Order No. 15, Judge Calabrese has updated the Records Collection Pool by removing 48 plaintiffs and replacing them with newly selected individuals. This ensures the bellwether trial pipeline remains active as some plaintiffs have voluntarily dismissed their suits or failed to meet documentation requirements.
June 2, 2025
- Suboxone Settlement Expectations: While some speculation suggests an early Suboxone settlement, a more realistic expectation points to late 2025. This timeline aligns with the defense's focus on the approaching three-year statute of limitations, which may influence their strategy to manage the volume of claims and contain financial risk.
May 24, 2025
- Bellwether Trial Protocol Established: Amended Case Management Order No. 15 outlines a comprehensive protocol for selecting bellwether trial plaintiffs in the federal Suboxone litigation. The process begins with a 500-member Records Collection Pool, followed by a phased narrowing down to six potential trial candidates, ultimately resulting in four single-plaintiff trials.
May 18, 2025
- Indivior's Litigation Strategy Under Scrutiny: Indivior's potential strategy of relying on jurors' perceptions of individuals in addiction recovery is being questioned. There is concern that underestimating juror empathy for plaintiffs who experienced dental damage from Suboxone could lead to significant financial costs for the company if cases proceed to trial.
May 2, 2025
- MDL Case Count Nears 900: The Suboxone tooth decay litigation now has 896 pending cases. The upcoming ability for lawyers to file lawsuits in blocks of 100 is expected to lead to a significant increase in new filings in the near future.
April 29th, 2025
- 3 Year SOL States No Longer Accepted: Going forward, we will only be accepting states for the Suboxone Lawsuit with 4+ SOL years, listed below.
-
- Florida: Statute of Limitations for Product Liability: 4 Years
- Maine: Statute of Limitations for Product Liability: 6 Years
- Minnesota: Statute of Limitations for Defective Drug Case: 6 Years
- Missouri: Statute of Limitations for Product Liability: 5 Years
- North Carolina: Statute of Limitations for Product Liability: 6 Years
- North Dakota: Statute of Limitations for Product Liability: 10 Years
- Wyoming: Statute of Limitations for Product Liability: 4 Years
April 16, 2025
- Upcoming Case Management Conference: The parties will address key developments in plaintiff and defendant discovery at tomorrow’s conference. Plaintiff Discovery Updates: Progress includes the submission of a Revised Schedule A and completed census forms, and the parties are working on protocols for Core Discovery and the Bellwether Trial Pool. Defense Discovery Updates: The parties have conferred on 30(b)(6) deposition notices without disputes, and Defendants will produce the full regulatory file for Sublocade, with plaintiffs withdrawing a specific search term. Other agenda items include addressing non-compliance with medical records requests, providing an update on newly filed cases, and discussing the joinder complaint process.
April 1, 2025
- Suboxone MDL Caseload Steady, with Increase Expected: As of April 1, the Suboxone tooth decay MDL maintains 896 pending cases. While there were no new cases added in February or March, a significant increase in filings is anticipated soon due to a recent order that streamlines the filing process for plaintiffs.
March 14, 2025
- Judge Issues Order Streamlining Case Filings: Judge Calabrese has issued Case Management Order No. 14, allowing up to 100 plaintiffs to file under a single complaint with one initial filing fee. This move aims to reduce costs, simplify case management, and prevent a flood of individual lawsuits.
March 13, 2025
- Reduction in "Schedule A" Claims: The number of "Schedule A" complaints in the Suboxone MDL has been reduced from approximately 9,600 to 8,611. This reduction is due to attorneys removing cases that did not prove viable after further investigation.
March 5, 2025
- No New Cases Added to Suboxone MDL: The Suboxone tooth decay MDL did not see any new cases added in February, marking the first month without new filings since the MDL began. There are currently 896 pending cases.
March 4, 2025
- Indivior's Potential Miscalculation: There is speculation that Indivior may be underestimating the strength of the Suboxone lawsuits and the potential for substantial jury verdicts. The plaintiffs, who suffered severe dental damage from Suboxone, are likely to garner sympathy from jurors, potentially leading to significant payouts.
February 26, 2025
- New Suboxone Lawsuit Filed: A Washington resident has filed a lawsuit alleging that the manufacturers of Suboxone film failed to warn about the drug's potential to cause severe dental damage.
February 21, 2025
- New Order Streamlines Medical Record Collection: The MDL judge has issued an order establishing rules for the efficient collection of medical and dental records in the Suboxone litigation. The order mandates that providers must comply with requests within 30 days and outlines penalties for non-compliance.
February 13, 2025
- Status Conference Held in Suboxone Litigation: A status conference was held to address procedural and administrative matters in the Suboxone litigation. Key issues discussed included the withdrawal of counsel for certain plaintiffs, ESI discovery protocols, and the production of the new drug application for Sublocade. The next status conference is scheduled for March 11, 2025.
Speak to a Suboxone Lawyer Today. Click HERE to see if you qualify.
For years, Suboxone was seen as a lifeline for people trying to break free from opioid addiction. Doctors prescribed it, believing it was a safer alternative. But what many never expected was the damage it could cause to their teeth—something that was never mentioned on warning labels until 2022.
If you've noticed cavities, cracked teeth, or sudden tooth loss after taking Suboxone, you're not alone. Many people have experienced the same thing. The worst part? Nobody warned them.
The link between Suboxone and severe dental problems isn’t just speculation. The FDA issued a public warning in 2022 after receiving reports from hundreds of patients. By then, the damage was already done. Some people lost a single tooth, others lost several, and many were left with painful infections, abscesses, and costly dental treatments they never expected.
Now, lawsuits are being filed against Indivior, the manufacturer of Suboxone, for failing to warn people about what this medication could do to their teeth.
How Does Suboxone Cause Dental Damage?
If you’ve been told that you just have bad teeth or that it’s your fault for not taking better care of them, that’s not the full picture. People who took Suboxone and now have serious dental problems didn’t suddenly forget to brush their teeth or go to the dentist.
The problem is the way Suboxone is taken.
Suboxone is a dissolvable strip placed under the tongue or between the cheek and gum. While that might seem convenient, the medication itself is highly acidic. Holding it in the mouth for minutes at a time exposes teeth to acid longer than normal, breaking down enamel and making it easier for cavities to form.
On top of that, Suboxone can cause dry mouth, which makes things even worse. Saliva protects teeth by washing away bacteria and keeping enamel strong. When there isn’t enough saliva, bacteria grow, plaque builds up, and decay happens faster than usual.
These two factors—constant acid exposure and dry mouth—create the perfect conditions for tooth decay, gum disease, and tooth loss.
Why Weren’t Patients Warned?
People who were prescribed Suboxone had no idea this could happen. Dentists weren’t told either. So when patients started noticing severe decay, they were left blaming themselves—when in reality, Suboxone was the cause.
The lawsuits claim that Indivior knew or should have known about these risks but failed to warn doctors, dentists, or patients.
By the time the FDA issued its warning in 2022, countless people had already suffered:
- People who had perfect dental health before taking Suboxone suddenly needed root canals, extractions, or implants.
- Some lost their front teeth, making it difficult to eat or even smile with confidence.
- Many were left with dental bills they couldn’t afford, forcing them to live with pain and embarrassment.
Had the risks been disclosed sooner, people could have:
- Chosen a different medication.
- Taken extra steps to protect their teeth.
- Talked to their dentist about preventive care.
But that warning came too late for many.
Speak to a Suboxone Lawyer Today. Click HERE to see if you qualify.
How Bad Is the Damage?
For some, it started with a few cavities that spread quickly. Others noticed their teeth becoming brittle, cracking, or breaking apart. In more severe cases, people have lost multiple teeth or developed infections that required surgery.
Dental problems linked to Suboxone include:
- Tooth decay (cavities appearing quickly, even in teeth that were previously healthy)
- Tooth fractures (teeth breaking apart or crumbling)
- Tooth loss (losing one or multiple teeth unexpectedly)
- Abscesses and infections (painful swelling that can require surgery)
- Gum disease (severe inflammation that can lead to tooth loss)
Some patients had no history of dental problems before taking Suboxone, making the sudden decay even more shocking.
The Cost of Fixing Suboxone-Related Dental Damage
Unlike medical care, dental treatments aren’t always covered by insurance. This means many people are left paying thousands—sometimes tens of thousands—out of pocket for:
- Fillings and crowns
- Root canals and extractions
- Gum disease treatments
- Implants, bridges, or dentures
For those who can’t afford treatment, the alternative is living with pain, infection, or missing teeth. No one should have to make that choice—especially when they were never warned about the risks in the first place.
Who Qualifies for a Suboxone Lawsuit?
Lawsuits are being filed against Indivior for failing to warn about these risks. If you or someone you love took Suboxone before June 2022 and developed tooth decay, loss, or other dental problems, you may be eligible. Speak to a Suboxone Lawyer today.
This isn’t about blaming people for taking a medication prescribed to them—it’s about holding a company accountable for what they didn’t tell people.
- Were your teeth healthy before taking Suboxone?
- Did you experience unexpected decay, loss, or infections?
- Have you needed expensive dental work—or still need it?
If you answered yes, you’re not alone. Many people are coming forward after realizing it wasn’t just them—it was the medication.
Don’t wait to learn more about your options. Speak to a Suboxone Lawyer Today. Click HERE to see if you qualify.
